Linfeng He (Yunxia Li)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Top Venues

Advanced healthcare materials

Oxidative medicine and cellular longevity

BioMed research international

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Lihong Gong, Honglin Zhou, Shenglin Zhang, Cheng Wang, Ke Fu, Cheng Ma, Yafang Zhang, Cheng Peng, Linfeng He
CD44-Targeting Drug Delivery System of Exosomes Loading Forsythiaside A Combats Liver Fibrosis via Regulating NLRP3-Mediated Pyroptosis. Advanced healthcare materials (2023)
Lihong Gong, Honglin Zhou, Shenglin Zhang, Cheng Wang, Ke Fu, Cheng Ma, Yafang Zhang, Cheng Peng, Linfeng He
CD44-targeting Drug Delivery System of Exosomes Loading Forsythiaside A Combats Liver Fibrosis via Regulating NLRP3-mediated Pyroptosis. Advanced healthcare materials (2023)
Yafang Zhang, Cheng Ma, Linfeng He, Liao Li, Chaocheng Guo, Cheng Wang, Lihong Gong, Honglin Zhou, Ke Fu, Cheng Peng, Yunxia Li
Tetramethylpyrazine Protects Endothelial Injury and Antithrombosis via Antioxidant and Antiapoptosis in HUVECs and Zebrafish. Oxidative medicine and cellular longevity 2022 (2022)
Mengting Zhou, Naihua Hu, Meichen Liu, Ying Deng, Linfeng He, Chaocheng Guo, Xingtao Zhao, Yun-Xia Li
A Candidate Drug for Nonalcoholic Fatty Liver Disease: A Review of Pharmacological Activities of Polygoni Multiflori Radix. BioMed research international 2020 (2020)
Xingtao Zhao, Liao Li, Mengting Zhou, Meichen Liu, Ying Deng, Linfeng He, Chaocheng Guo, Yun-Xia Li
An Overview of the Mechanism of Penthorum chinense Pursh on Alcoholic Fatty Liver. Evidence-based complementary and alternative medicine : eCAM 2020 (2020)